10-Q: Este Lauder Returns to Profit Amid Restructuring Efforts
Quarterly Report
Este Lauder Companies reported a return to net earnings in Q1 FY26, driven by sales growth in fragrance and skin care, and benefits from its Profit Recovery and Growth Plan, despite ongoing market challenges.
Summary
- Net sales increased by 4% to $3,481 million for the three months ended September 30, 2025, compared to $3,361 million in the prior-year period (3% increase in constant currency).
- The company achieved net earnings of $47 million, or $0.13 per diluted share, a significant improvement from a net loss of $156 million, or $(0.43) per diluted share, in the prior-year period.
- Operating income turned positive at $169 million, compared to an operating loss of $121 million in the prior-year period.
- Gross profit increased to $2,554 million from $2,433 million, with gross margin improving to 73.4% from 72.4%.
- The Profit Recovery and Growth Plan (PRGP) is underway, with an estimated net reduction of 5,800 to 7,000 positions globally (9-11% of positions as of June 30, 2023).
- Cumulative charges approved for the Restructuring Program through October 26, 2025, totaled $852 million, with $697 million recorded through September 30, 2025.
- The company expects the Restructuring Program to yield annual target gross benefits of $800 million to $1,000 million before taxes, aiming for a return to a double-digit operating margin over the next few years.
- Cash and cash equivalents decreased to $2,219 million at September 30, 2025, from $2,921 million at June 30, 2025.
- Net cash flows used for operating activities improved to $(340) million from $(670) million in the prior-year period.
- A charge of $159 million was recorded in the prior-year period (Q1 FY25) for talcum litigation settlement agreements, which did not recur in the current period.
Sentiment
Score: 6
Explanation: The company demonstrated a significant financial turnaround from a loss to a profit, driven by restructuring benefits and growth in key segments like fragrance and Asia/Pacific. However, persistent macro-economic headwinds, challenges in major markets like the U.S. and Western Europe, and ongoing legal uncertainties temper the overall positive sentiment.
Positives
- Net earnings of $47 million represent a significant turnaround from a net loss of $156 million in the prior-year period.
- Operating income improved substantially to $169 million from an operating loss of $121 million year-over-year.
- Gross margin increased by 100 basis points to 73.4%, reflecting net benefits from the PRGP, including reductions in promotional activity and excess inventory.
- Net sales grew by 4% (3% in constant currency), driven by strong performance in fragrance (+14%) and skin care (+3%).
- Asia/Pacific net sales increased by 8% (9% in constant currency), primarily due to higher travel retail business and improved consumer sentiment in Mainland China.
- Mainland China net sales increased by 9% (9% in constant currency), benefiting from new product launches and the expansion of The Ordinary.
- The Restructuring Program is progressing, with expected annual gross benefits of $800 million to $1,000 million, aiming for a double-digit operating margin in the coming years.
- Net cash flows used for operating activities significantly improved, decreasing from $(670) million to $(340) million.
- Interest expense decreased to $86 million from $92 million, reflecting a lower average debt balance.
Negatives
- Makeup net sales decreased by 1% to $1,030 million, primarily due to lower sales from Bobbi Brown and Too Faced.
- Hair care net sales decreased by 7% to $129 million, driven by planned reductions in promotional activity and exit from underperforming doors for Aveda.
- Net sales in The Americas decreased by 2% to $1,174 million, reflecting continued challenges in department stores, including store closures and softness in certain retailers.
- Cash and cash equivalents decreased by $702 million from June 30, 2025, to September 30, 2025.
- Dividends paid to stockholders decreased to $127 million from $240 million in the prior-year period, and the quarterly dividend per share was reduced to $0.35 from $0.66.
- Interest income and investment income, net, decreased to $30 million from $35 million, reflecting a lower average cash balance and lower average interest rates.
- The effective tax rate increased significantly to 56.9% from 13.3%, partly due to the loss before income taxes in the prior year, estimated unfavorable impact of new U.S. tax legislation, and a higher effective tax rate on foreign operations.
Risks
- Continued volatility and uncertainty in the global macro environment, including the risk of recession, currency volatility, and inflationary pressures.
- Weak travel retail conversion and subdued consumer sentiment in Western Europe.
- Ongoing challenges in U.S. department stores, including store closures related to retailer bankruptcy and elevated inventory levels for some brands.
- Anticipated adverse effects on fiscal 2026 profitability and cash flows from higher tariff rates, which could be material.
- Supply chain challenges, social and political issues, competitive pressures, legal and regulatory matters (including tariffs and sanctions), geopolitical tensions, and global security issues.
- Inflationary pressures on the cost base and their impact on consumer preferences.
- Potential negative impacts of organizational changes (Beauty Reimagined, PRGP) on suppliers, retailers, and other stakeholders.
- Challenges related to successfully outsourcing select services as part of the restructuring program.
- Declines in net sales and profitability could adversely impact goodwill and other intangible assets, as well as long-lived assets, potentially resulting in impairments.
- Uncertainty regarding the potential impact of the Pillar Two Global Anti-Base Erosion model rules in additional countries.
- The 'One Big Beautiful Bill Act' (U.S. tax legislation) is expected to have an unfavorable fiscal 2026 impact, with an $8 million impact in Q1 FY26.
- The ability to recognize deferred tax assets is dependent on generating sufficient taxable income in future periods, with a risk of additional material valuation allowances.
- Expiration of certain global tax regulations in fiscal 2026, if not extended, could increase the effective tax rate.
- Ongoing legal proceedings, including securities class action and derivative matters, with outcomes that are not yet reasonably assessable and could be material.
- Ongoing cosmetic talcum powder matters, with a range of reasonably possible losses in excess of accrued liabilities that cannot be reasonably estimated for cases outside of the settlement agreements.
Future Outlook
The company anticipates continued volatility and uncertainty, with challenges persisting in Western Europe and U.S. department stores. Higher tariff rates are expected to adversely affect fiscal 2026 profitability and cash flows, potentially materially. The Profit Recovery and Growth Plan, including the restructuring program, is expected to progressively rebuild profit margins in fiscal years 2025 and 2026, aiming for a return to a double-digit operating margin over the next few years. The company is monitoring the impact of new U.S. tax legislation and global minimum tax rules, as well as potential valuation allowances on deferred tax assets.
Management Comments
- "We continue to believe that the best way to increase long-term stockholder value is to provide superior products and services in the most efficient and effective manner while recognizing shifts in consumers behaviors and shopping practices."
- "With the transition of leadership in the second and third quarters of fiscal 2025, we have embarked on 'Beauty Reimagined,' a strategic vision which focuses on accelerating best-in-class consumer coverage, creating transformative innovation, boosting consumer-facing investments, fueling sustainable growth through bold efficiencies and reimagining the way we work, including through the expansion of the Profit Recovery and Growth Plan."
Industry Context
The company, a leading global beauty products manufacturer, is navigating a challenging retail environment characterized by weak travel retail conversion, subdued consumer sentiment in Western Europe, and headwinds in U.S. department stores, including store closures and retailer bankruptcies. Despite these challenges, the company is seeing signs of stabilization and improvement in Mainland China. The ongoing restructuring program and 'Beauty Reimagined' strategy aim to enhance efficiency and adapt to evolving consumer behaviors and shopping practices, positioning the company for long-term growth in the competitive luxury and prestige beauty market.
Comparison to Industry Standards
- NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer | Former Chief Executive Officer (unnamed in this filing) | Stéphane de La Faverie (President and Chief Executive Officer) | Fiscal 2025 second and third quarters (transition of leadership) | Transition of leadership, as part of 'Beauty Reimagined' strategic vision. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Stockholder Litigation Demands Review | The Board of Directors received stockholder litigation demands related to the alleged course of conduct identified in the securities class action. A committee of the Board has been formed to review these demands and make recommendations. | After March 22, 2024 (filing of consolidated amended class action complaint) | Indicates increased scrutiny on corporate oversight and potential for further legal action or internal governance adjustments based on committee recommendations. |
Legal Proceedings
- Securities Class Action and Derivative Matters: A consolidated class action complaint alleges materially false and misleading statements from February 3, 2022, to October 31, 2023. The motion to dismiss was denied on March 31, 2025. Multiple stockholder derivative actions have also been filed, alleging breach of fiduciary duty, unjust enrichment, waste, gross mismanagement, and insider trading. The outcome of these matters cannot be reasonably assessed at this time.
- Cosmetic Talcum Powder Matters: 91 individual cases are pending against the company as of September 30, 2025, alleging asbestos contamination. The company recorded a $159 million charge in Q1 FY25 for settlement agreements covering over 200 pending cases and potential future claims through December 31, 2029. The range of reasonably possible losses in excess of accrued liabilities for cases outside these agreements cannot be reasonably estimated.
Related Party Transactions
- NA
Stakeholder Impact
- Shareholders: Experienced a significant turnaround from a net loss to net earnings, but also a reduction in quarterly dividends. The ongoing restructuring aims to rebuild profit margins and long-term stockholder value, but legal proceedings and market volatility pose risks.
- Employees: The Restructuring Program involves a net reduction of approximately 5,800 to 7,000 positions globally (9-11% of workforce), impacting employee-related costs and potentially morale, though some employees may be retrained and redeployed.
- Customers: New product launches and strategic pricing actions are intended to enhance customer experience and value. However, challenges in department stores and travel retail may affect product availability and shopping experience in certain channels.
- Suppliers: The restructuring program, including outsourcing select services, and inflationary pressures could impact supplier relationships and terms.
- Creditors: The company's long-term debt is rated Awith a negative outlook by Standard & Poor's and A3 with a negative outlook by Moody's, indicating a stable but monitored credit profile. Lower average debt balance reduced interest expense.
Next Steps
- Continue implementing the Profit Recovery and Growth Plan (PRGP) and its expanded restructuring program, with initiatives expected to be approved by the end of fiscal 2026 and substantially completed by the end of fiscal 2027.
- Monitor and assess the potential effects of new and existing tariffs, implementing additional mitigation measures as needed.
- Continue to monitor and evaluate the potential impact of incorporating the global minimum tax in additional countries.
- Evaluate the potential impact of provisions from the 'One Big Beautiful Bill Act' that are expected to be effective in future fiscal years.
- Monitor global tax regulations that may expire during fiscal 2026, which, if not extended, could increase the effective tax rate.
- Defend vigorously against ongoing securities class action and derivative matters.
- Continue to defend against cosmetic talcum powder matters, while monitoring the range of reasonably possible losses.
Key Dates
| Date | Description |
|---|---|
| 2022-12 | Company suspended the repurchase of shares of its Class A Common Stock under its publicly announced program. |
| 2023-02-03 | Alleged start of materially false and misleading statements in securities class action complaint. |
| 2023-10-31 | Alleged end of materially false and misleading statements in securities class action complaint. |
| 2023-11-01 | Company launched the Profit Recovery and Growth Plan (PRGP). |
| 2023-12-07 | Securities class action complaint filed against the company and its then CEO and CFO. |
| 2023-12 | FASB issued authoritative guidance to amend and enhance existing annual income tax disclosures (ASU 2023-09), effective for the company's fiscal year ending June 30, 2026. |
| 2024-01-22 | Separate securities class action complaint filed against the company and its then CEO and CFO. |
| 2024-02-01 | Company committed to the two-year restructuring program component of the PRGP. |
| 2024-02-05 | Company announced a two-year restructuring program as a component of the PRGP. |
| 2024-02-20 | Two purported securities class actions were consolidated into one action. |
| 2024-03-15 | Stockholder derivative action complaint filed against certain officers and directors, later voluntarily dismissed. |
| 2024-03-22 | Plaintiffs filed their consolidated amended class action complaint. |
| 2024-04 | Stockholder derivative complaints were voluntarily dismissed without prejudice. |
| 2024-07-01 | Beginning of the three months ended September 30, 2024, for comparative financial data. |
| 2024-09-03 | Company issued 195,940 shares of Class A Common Stock to its former Chief Executive Officer in accordance with PSUs granted in February 2018. |
| 2024-09-30 | End of the three months ended September 30, 2024, for comparative financial data. |
| 2024-10-31 | Company reached agreements for talcum litigation settlement, recording a $159 million charge in Q1 FY25. |
| 2024-11 | FASB issued authoritative guidance requiring disaggregation of income statement expenses (ASU 2024-03), effective for the company's fiscal year ending June 30, 2028. |
| 2025-01 | FASB issued authoritative guidance requiring disaggregation of income statement expenses (ASU 2025-01), effective for the company's fiscal year ending June 30, 2028. |
| 2025-01-01 | Start date for resolving potential future cosmetic talcum powder claims under settlement agreements. |
| 2025-02-03 | Company committed to the expansion of the PRGP, including an expansion of the restructuring program. |
| 2025-03-31 | Court denied defendants' motion to dismiss in the consolidated securities class action. |
| 2025-05-08 | Two additional stockholder derivative action complaints filed in the United States District Court for the Southern District of New York. |
| 2025-06-23 | Another stockholder derivative action complaint filed in the Supreme Court of the State of New York in Kings County. |
| 2025-06-30 | End of the fiscal year 2025. |
| 2025-07-01 | Beginning of the three months ended September 30, 2025, for current financial data. Company reorganized its geographic regions. |
| 2025-07-04 | New U.S. tax legislation, the 'One Big Beautiful Bill Act,' was enacted. |
| 2025-07 | FASB issued authoritative guidance related to the estimation of expected credit losses (ASU 2025-05), effective for the company's first quarter of fiscal 2027. |
| 2025-08-19 | Dividend of $0.35 per share declared. |
| 2025-09-02 | Company issued 68,578 shares of Class A Common Stock to its former Chief Executive Officer in accordance with PSUs granted in March 2021. Also issued 85,927 shares of Class A Common Stock to its former Chief Executive Officer in accordance with price-vested unit awards granted in March 2021. |
| 2025-09-02 | Record date for the $0.35 per share dividend declared on August 19, 2025. |
| 2025-09-15 | Additional stockholder derivative action complaint filed in Delaware Chancery Court. |
| 2025-09-16 | Payable date for the $0.35 per share dividend declared on August 19, 2025. |
| 2025-09-26 | Additional stockholder derivative action complaint filed in Delaware Chancery Court. |
| 2025-09-30 | End of the quarterly period for this Form 10-Q. |
| 2025-09 | FASB issued authoritative guidance to modernize accounting for internal-use software (ASU 2025-06), effective for the company's first quarter of fiscal 2029. |
| 2025-10-23 | Outstanding shares of Class A and Class B Common Stock reported. Credit ratings updated. |
| 2025-10-26 | Cumulative charges approved for the Restructuring Program through this date totaled $852 million. |
| 2025-10-29 | Dividend of $0.35 per share declared. |
| 2025-10-30 | Date of filing of this Form 10-Q. |
| 2025-11-28 | Record date for the $0.35 per share dividend declared on October 29, 2025. |
| 2025-12-15 | Payable date for the $0.35 per share dividend declared on October 29, 2025. |
| 2029-12-31 | End date for resolving potential future cosmetic talcum powder claims under settlement agreements. |
Recommendation
holdThe company's return to profitability and positive operating income, coupled with an improving gross margin, indicates effective execution of its Profit Recovery and Growth Plan. The strategic vision 'Beauty Reimagined' and ongoing restructuring efforts are designed to drive long-term value. However, significant headwinds persist in key markets like the U.S. and Western Europe, travel retail conversion remains weak, and the company faces material risks from tariffs, macro-economic volatility, and ongoing legal proceedings. The reduction in dividends also signals a cautious approach. For a seasoned investor, the current environment presents a mixed picture of recovery and persistent challenges, warranting a 'hold' position to observe the sustained impact of the restructuring and the company's ability to navigate external pressures.
Keywords
Este Lauder, EL, Beauty Reimagined, Profit Recovery and Growth Plan, PRGP, Skin Care, Makeup, Fragrance, Hair Care, SEC Filing, 10-Q, Quarterly Report, Financial Results, Restructuring, Travel Retail, Mainland China, Talcum Litigation, Securities Class Action, Global Minimum Tax, Tariffs, Consumer Goods, Luxury Brands
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.